Synairgen (LON:SNG) Shares Pass Below Two Hundred Day Moving Average of $22.91
Synairgen (LON:SNG) Shares Pass Below Two Hundred Day Moving Average of $22.91
Synairgen plc (LON:SNG – Get Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 22.91 ($0.28) and traded as low as GBX 16.10 ($0.20). Synairgen shares last traded at GBX 16.80 ($0.21), with a volume of 218,665 shares changing hands.
在周四的交易中，Synairgen plc(伦敦股票代码：SNG-GET)跌破了200日移动均线。该股的200日移动均线为22.91英镑(合0.28美元)，交易价格低至16.10英镑(合0.20美元)。Synairgen的股票最后交易价格为16.80英镑(0.21美元)，成交量为218,665股。
Synairgen Stock Up 5.0 %
Synairgen股价上涨5.0%
The company has a quick ratio of 6.35, a current ratio of 6.35 and a debt-to-equity ratio of 0.09. The company has a market capitalization of £33.83 million and a price-to-earnings ratio of -0.69. The stock's fifty day moving average price is GBX 18.65 and its 200-day moving average price is GBX 22.91.
该公司的速动比率为6.35，流动比率为6.35，债务权益比为0.09。该公司市值3383万GB，市盈率为-0.69。该股的50日移动均线价格为18.65英镑，200日移动均线价格为22.91英镑。
About Synairgen
关于Synairgen
(Get Rating)
(获取评级)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Synairgen plc发现和开发治疗呼吸系统疾病的药物。该公司开发的产品有：治疗新冠肺炎的乙型吸入型干扰素SG001；治疗感冒和流感引起的哮喘的乙型干扰素吸入剂；治疗或预防慢性阻塞性肺病的乙型干扰素第二阶段临床试验；以及治疗特发性肺纤维化的LXL2抑制剂。
Recommended Stories
推荐故事
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
- Inflation and the Energy Crisis are Two Freight Trains on a Collision Course – Here's How to Prepare
- Is Enterprise Products Partners Fairly Valued?
- 拖拉机库存能否突破杯柄收购点？
- 现在不是购买Lennar的时候，但时机即将到来
- 马伦汽车公司改变游戏规则的消息
- 通货膨胀和能源危机是两列相撞的货运列车--以下是如何做好准备的
- 企业产品合作伙伴是否得到公平评价？
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
接受Synairgen Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Synairgen和相关公司的最新新闻和分析师评级的每日简明摘要。